F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Hot Fund

Speciale Invest

specialeinvest.com · Chennai, India

“We back bold, early-stage founders building disruptive innovations deeply rooted in science, engineering, and technology, across Novel Energy & Planetary Health, Human Longevity & Synthetic Biology, Beyond Earth & Space Tech, Advanced Manufacturing, and AI Led Software. We prioritize exponential over incremental change and are often the first institutional check.”

$800K – $1.2M
Check Size
Leads
Lead Tendency
$140M
AUM
01Investment Thesis

We back bold, early-stage founders building disruptive innovations deeply rooted in science, engineering, and technology, across Novel Energy & Planetary Health, Human Longevity & Synthetic Biology, Beyond Earth & Space Tech, Advanced Manufacturing, and AI Led Software. We prioritize exponential over incremental change and are often the first institutional check.

Exclusion Criteria

Not a fit for companies that have already raised $1-2M+ before approaching them, or for incremental (non-science/engineering-first) businesses; the firm is a seed-stage-only investor and does not lead new Series A entries.

02Investment Team
VR
Vishesh Rajaram
Founding Partner
AR
Arjun Rao
Founding Partner
VJ
Vijay Jacob
General Partner
KS
Krishnaswamy Srinivasan
General Partner & Chief Financial Officer
DM
Dr Mridula Menon
Head of Investor Relations & Chief of Staff
VR
Vishnu Rajeev
Investment Partner
SC
Sunil Cavale
Investment Principal
NK
Nithish Kumar
Investment Manager
AS
Ahammad Shibil
AVP - Investments
CG
Chethan Gowda
Investment Analyst
VK
Varun KS
Investment Analyst
AS
Arun Shanmugam
Investment Analyst
BM
Balaji MP
Investment Analyst
03F4 Research Brief

Speciale Invest Research

Investment Thesis

Speciale Invest is a Chennai-based, pure-play DeepTech venture capital firm founded in 2017 by Vishesh Rajaram and Arjun Rao. The firm backs bold, early-stage founders building disruptive innovations deeply rooted in science, engineering, and technology — ideas with the power to redefine entire industries. It organizes its focus around five pillars: Novel Energy & Planetary Health, Human Longevity & Synthetic Biology, Beyond Earth & Space Tech, Advanced Manufacturing, and AI Led Software. The firm explicitly prioritizes exponential over incremental change and positions itself as a patient, people-first institutional investor that is often the first check into a company. With Fund III (closed August 2025), Speciale is leaning further into sovereign-tech and globally scalable IP from India, citing India's geopolitical position and the need to reduce dependence on foreign technology as a driving rationale.

Stage Focus

Speciale invests almost exclusively at pre-seed and seed. The firm states plainly that it does not do Series A follow-ons as a new entry point ("we are a seed stage VC only") — its later checks into existing portfolio companies are follow-on reserves, not new-logo Series A bets. It is typically the first institutional investor in a company, sometimes following small pre-institutional rounds (<$200K) from accelerators or friends and family.

Check Size

Fund III writes initial tickets of roughly ₹7–10 crore (~$800K–$1.14M), with flexibility to go higher in select cases. Historically the firm's stated sweet spot is ~$1M. Roughly 50–60% of total fund corpus is reserved for follow-on investments, and Fund III targets increased ownership (~15%, up from ~10% in Fund II and ~5% in Fund I).

Lead Tendency

Speciale usually leads or co-leads the first institutional round into a company (e.g., co-leading InspeCity's ₹100 crore Pre-Series A in August 2026), though it has also collaborated with co-investors.

Recent Activity

Fund III closed oversubscribed at ₹600 crore (~$69M) against a ₹500 crore target in August 2025, with more than half from repeat LPs. The fund targets 18–20 early-stage deeptech startups across AI infrastructure, spacetech, climatetech, quantum systems, advanced manufacturing, and dual-use defense through 2029. Recent investments include Nucleovir Therapeutics (oncolytic virus therapy, June 2026), H2LooP (physical AI infrastructure, April 2026), a follow-on into Peptris (AI drug discovery, February 2026), a follow-on into e-TRNL Energy (battery architecture, February 2026), DashamLabs (silica aerogel manufacturing, October 2025), Morphing Machines (reconfigurable chip, Series A follow-on, October 2025), Unmannd (aerial autonomy/defense drones, September 2025), and VyomIC (sovereign PNT/navigation, September 2025).

Portfolio Highlights

Notable portfolio companies include Agnikul Cosmos (3D-printed rocket engines, first check in 2018), GalaxEye (SAR satellite imaging), ePlane Company (air taxis), Ultraviolette Automotive (electric motorcycles, now exporting to 10 European nations), CynLr (industrial machine-vision robotics), QNu Labs (quantum-safe cryptography), Mindgrove Technologies (indigenous semiconductor design), Newtrace (green hydrogen electrolyzers), Metastable Materials (battery-waste metal recovery), InspeCity (in-space servicing stack), Anubal Fusion (fusion energy), Sthyr Energy (long-duration energy storage), and eka.care (digital health platform). The firm reports nine M&A exits to date and describes itself, via its own impact stats, as having deployed $140M+ across 45+ companies over 9+ years.

Team

  • Vishesh Rajaram — Founding Partner (managing partner/managing director in press coverage; formerly a principal at Ventureast)
  • Arjun Rao — Founding Partner
  • Vijay Jacob — General Partner
  • Krishnaswamy Srinivasan — General Partner & Chief Financial Officer
  • Dr Mridula Menon — Head of Investor Relations & Chief of Staff
  • Vishnu Rajeev — Investment Partner
  • Sunil Cavale — Investment Principal
  • Nithish Kumar — Investment Manager
  • Ahammad Shibil — AVP - Investments
  • Chethan Gowda — Investment Analyst
  • Varun KS — Investment Analyst
  • Arun Shanmugam — Investment Analyst
  • Balaji MP — Investment Analyst

Decision Process

Speciale runs a five-stage process: initial materials review, a first meeting, a follow-up with at least one partner, a full partner meeting followed by an internal investment committee (IC) discussion, and a final meeting where founders present to the entire team. The firm says it aims to give an answer at each stage within roughly 48 hours and positions its overall process as "quick and transparent."

Founder Preferences

Speciale explicitly welcomes very early teams — "as small as 2-3 people with an idea" — and is often the first investor a startup has ever had. It looks for science- and engineering-first founders tackling large, meaningful technical problems rather than incremental improvements, and is comfortable investing pre-product, pre-pitch-deck. It is skeptical of founders who have already raised $1–2M+ before approaching them, viewing that as a poor stage fit.

Geographic Focus

Speciale is India-focused with global ambition — it backs India-headquartered, engineering-first teams building technology intended to compete and sell globally ("sovereign tech and globally scalable IP from India"). The firm is headquartered in Chennai (The Grid, Central Ave, Kesavaperumalpuram) with an additional office in Bengaluru (WeWork Galaxy, Ashok Nagar).

04Selected Portfolio
Aerospace & Defense
Agnikul·E-Plane·Astrogate Labs·Unmannd·VyomIC·Inbound Aerospace
Biotech & Life Sciences
Fermbox Bio·Nucleovir Therapeutics·Peptris
Climate & Sustainability
DashamLabs·InspeCity·Sthyr Energy·Anubal Fusion·Metastable Materials·e-TRNL Energy
Energy & Power
Newtrace
Enterprise Software
GalaxEye·Airboxr·WingMan·H2LooP·Protecto
Healthcare & Digital Health
Eka.care
HR Tech & Future of Work
StepChange
Mobility & Transportation
Ultraviolette·Ultraviolette Automotive
Robotics & Automation
CynLr
Security & Cybersecurity
QNu Labs
Semiconductors & Hardware
Morphing Machines·Mindgrove Technologies
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (25) →
Published a thesis essay reflecting on the state and prospects of the Indian biotech ecosystem.
ESSAY·specialeinvest.com
Added recently
Published an essay on portfolio company StepChange's approach to profitably pricing climate risk in the Global South.
ESSAY·specialeinvest.com
Added recently
Co-led InspeCity's INR 100Cr Pre-Series A round, tripling down on a company first backed in 2023 and again in 2025.
INVESTMENT·specialeinvest.com
AUG 27, 2026
Invested in Nucleovir Therapeutics, an oncolytic-virus cancer immunotherapy company.
INVESTMENT·specialeinvest.com
JUN 11, 2026
Invested in H2LooP, building a foundational layer for physical AI in mission-critical systems.
INVESTMENT·specialeinvest.com
APR 7, 2026
06Frequent co-investors
IV
IIMA Ventures
Both backed 4 of the same companies
Morphing Machines, Agnikul, E-Plane, CynLr
NC
Navam Capital
Both backed 4 of the same companies
Morphing Machines, Agnikul, GalaxEye, e-TRNL Energy
D
DeVC
Both backed 2 of the same companies
Morphing Machines, InspeCity
MG
MountTech Growth Fund - Kavachh
Both backed 2 of the same companies
GalaxEye, InspeCity
Find the investors for your round→
07Similar Firms
NC
Navam Capital
Pre-Seed · Seed
→
VV
Vsquared Ventures
$540K – $5.4M · Pre-Seed · Seed
→
DC
Divergent Capital
$250K – $1M · Pre-Seed · Seed
→
RV
Riceberg Ventures
$250K – $1M · Pre-Seed · Seed
→
OH
Overlap Holdings
Seed · Series A
→
Quick Reference
Check Size
$800K – $1.2M
Stages
Pre-Seed · Seed
AUM
$140M
Decision
Investment Committee
Warm Intro
Not Required
Involvement
Advisor
Location
Chennai, India
Sector Focus
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationMobility & TransportationDeveloper Tools & InfrastructureSecurity & CybersecurityEnergy & PowerHealthcare & Digital Health
Models
DeepTech HardwareDeepTech Software
Technology
AI/MLRoboticsSpace TechAdvanced MaterialsSemiconductors
See all Manufacturing & Industrial investors →See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →
Visit specialeinvest.com ↗

See how Speciale Invest matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationMobility & TransportationDeveloper Tools & InfrastructureSecurity & CybersecurityEnergy & PowerHealthcare & Digital Health

See how Speciale Invest matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched September 11, 2026F4 Research Engine